Skip to content

Public FDA record

Z-1475-2024: 3M Tube Securement Device, Small, 1.7 IN/PO x 2.4 IN/PO, REF 1500U, Sterile; and 3M Tube Securement Devic

Recall record Z-1475-2024 for 3M Company - Health Care Business. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1475-2024
Company in FDA record
3M Company - Health Care Business
FDA classification date
Apr 3, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Manufacturing nonconformities are in some lots of the Tube Securement Device, such as the top film layer may be partially or completely missing and some devices may exhibit the appearance of an incorrect shape due to excess material not being removed from the product liner.

Source facts

Action
The recalling firm issued letters addressed to either the distributor, health care customer, or retailer dated 2/14/2024 via email or certified mail on 2/20/2024. The distributor letter explained the issue and provided the affected lot numbers with photographs embedded in the letter to illustrate where to find the model numbers and lot numbers that were affected. The distributors were to immediately discontinue distribution of the affected products and quarantine them for destruction. They were to complete the Distributor Acknowledgement Form to acknowledge they have read and understand the letter, to report if they have affected product in stock and have destroyed them per facility policy, and to email the completed form back to the recalling firm. The distributor is to notify any of their customers who have purchased the affected products using the enclosed Customer Letter dated 2/14/2024 and the Customer Acknowledgement Form. The customer letter enclosed with the distributor letter was similar to the distributor letter except it instructed them to contact the distributor for the next steps on requesting credit for the affected products before destruction and to complete the Customer Acknowledgement Form. The letter for the health care customer was similar to the distributor letter but it did not contain instructions to notify customers who were distributed the affected product. It did request the health care customer to ensure the notice was passed to all who need to be aware within their organization or to any department where the affected product has been transferred.
Initiated
2024-02-20
Root cause
Process control
Distribution
Worldwide distribution - US Nationwide distribution in the states of CA, CO, FL, IA, IL, IN, KS, MD, MN, NC, NH, NY, OH, PA, TX, VA, and WA, including PR. The countries of Australia, Austria, Canada, China, Finland, Germany, Ireland, New Zealand, Norway, Poland, Sweden, and the United Kingdom.
Recall number
Z-1475-2024
Recall status
Open, Classified
CDRH record ID
206179
FDA classified
2024-04-03
Recall event number
94039

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗